TRPV6 and cancer: This also suggests a possibility for the development of more potent THCV-inspired inhibitors with better selectivity, distribution patterns, and pharmacokinetics to fill a much-needed medicinal niche for fine-tuning TRPV6-mediated activity in numerous diseases, including cancer.